N/A
Loading page data
Please wait a moment
Loading page data
Please wait a moment
Second Floor, 150 Fleet Street,
London, EC4A 2DQ.
+44 203-837-5656
108 W 39th Street, Ste 1006,
PMB2219, New York, NY 10018
+1 646-878-6329
IT Unit No. 504, 5th Floor, Icon
Tower, Baner, Pune - 411045.
+91 906 779 3500
Myopia is referred to as nearsightedness which is a vision condition where nearby objects can be viewed clearly but not the farther ones. This condition occurs when the shape and structure refracts the light rays incorrectly. The images are focused in front of the retina and not on the retina which is normal. Myopia ranges from high to low and occurs in both children and adults. This condition is inherited in some cases. Major symptoms include defective vision.
Myopia management system includes wearing spectacles designed for specially myopia and contact lenses. The global prevalence of visual impairment disorder is expected to increase dramatically from 2000 to 2050. Currently, it is estimated that 537 million people suffer from high myopia. Increasing in number of eye disorders is attributed to unhealthy lifestyle habits like increased exposure to gadgets.
It is estimated that the prevalence of myopia is growing at unprecedented levels in the United States and even globally. Increasing prevalence of myopia among children and adult is a major driver for the Myopia management system market growth. Apart from the prevalence, various recent clinical studies and research are going on for changing the management of myopia. Research on myopia management will be a boon for many eye care practitioners and the eye care industry.
According to the World Health Organization, children with myopia will increase from 1.4 billion to 4.7 billion from 2000 to 2050. WHO also estimates prevalence of high myopia will grow from 163 million to 938 million. This estimation weighs approximately 10 percent of the world’s population. All these factors are expected to upswing the myopia management system market.
Studies also show that number of causative behind myopia are decreased outdoor play time among children and increased screen time on devices is a major cause of concern. However, avoidance to go to clinics and doctors for vision problems in lower economic regions can be a major setback to the myopia management system Market growth.
Another restraint is economic costs of vision disorder management are significant which is around $10 billion annually in the United States. Additionally, medical care, devices and vision aids and caregivers are not cost effective. These factors can hamper the myopia management system market growth.
COVID 19 pandemic impacted many industries including healthcare and medical devices. However, the impact on Myopia management systems can said to be low to moderate. New purchases might have suffered loss due to hampered supply chain and distribution. But this effect was temporary and got recovered post lockdown.
Some of the main market players for myopia management system Market are: Zeiss International, Essilor Ltd. Bausch & Lomb Incorporated, Johnson & Johnson Vision, and Alcon Vision Llc, Topcon Corporation, Haag-Streit UK, Ziemer Ophthalmic Systems AG, Nidek Co., Ltd., Cooper vision, Markennovy and others.
